Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy
- 1 April 1998
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 351 (9111) , 1233-1237
- https://doi.org/10.1016/s0140-6736(97)11329-0
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- A Preliminary Study of Growth Hormone in the Treatment of Dilated CardiomyopathyNew England Journal of Medicine, 1996
- Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of CardiomyopathiesCirculation, 1996
- Partial Left Ventriculectomy to Improve Left Ventricular Function in End-Stage Heart DiseaseJournal of Cardiac Surgery, 1996
- Differential Cardiac Effects of Growth Hormone and Insulin-like Growth Factor1 in the RatCirculation, 1996
- Reversal of Chronic Ventricular Dilation in Patients With End-Stage Cardiomyopathy by Prolonged Mechanical UnloadingCirculation, 1995
- Idiopathic Dilated CardiomyopathyNew England Journal of Medicine, 1994
- Reversible Dilated Cardiomyopathy Due to Growth Hormone DeficiencyAmerican Journal of Clinical Pathology, 1992
- Noninvasive evaluation of global left ventricular function with use of cine nuclear magnetic resonanceJournal of the American College of Cardiology, 1989
- Variability in the Quantitation of Circulating Growth Hormone Using Commercial ImmunoassaysJournal of Clinical Endocrinology & Metabolism, 1989
- Estimation of human myocardial mass with MR imaging.Radiology, 1988